Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023

Upgrades

According to Morgan Stanley, the prior rating for First Solar Inc FSLR was changed from Underweight to Equal-Weight. For the second quarter, First Solar had an EPS of $1.89, compared to year-ago quarter EPS of $0.52. At the moment, the stock has a 52-week-high of $232.00 and a 52-week-low of $115.66. First Solar closed at $186.48 at the end of the last trading period.

For MP Materials Corp MP, Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. MP Materials earned $0.09 in the second quarter, compared to $0.41 in the year-ago quarter. The stock has a 52-week-high of $36.67 and a 52-week-low of $19.18. At the end of the last trading period, MP Materials closed at $21.53.

For MACOM Technology Solutions Holdings Inc MTSI, Craig-Hallum upgraded the previous rating of Hold to Buy. MACOM Technology Solns earned $0.54 in the third quarter, compared to $0.73 in the year-ago quarter. The current stock performance of MACOM Technology Solns shows a 52-week-high of $85.42 and a 52-week-low of $48.53. Moreover, at the end of the last trading period, the closing price was at $81.04.

For Cenovus Energy Inc CVE, Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. In the second quarter, Cenovus Energy showed an EPS of $0.33, compared to $0.93 from the year-ago quarter. The stock has a 52-week-high of $22.17 and a 52-week-low of $14.45. At the end of the last trading period, Cenovus Energy closed at $20.20.

B of A Securities upgraded the previous rating for CME Group Inc CME from Underperform to Neutral. For the second quarter, CME Gr had an EPS of $2.30, compared to year-ago quarter EPS of $1.97. At the moment, the stock has a 52-week-high of $209.31 and a 52-week-low of $166.54. CME Gr closed at $202.53 at the end of the last trading period.

For ResMed Inc RMD, Needham upgraded the previous rating of Hold to Buy. In the fourth quarter, ResMed showed an EPS of $1.60, compared to $1.49 from the year-ago quarter. The current stock performance of ResMed shows a 52-week-high of $243.52 and a 52-week-low of $152.26. Moreover, at the end of the last trading period, the closing price was at $153.89.

Needham upgraded the previous rating for Semtech Corp SMTC from Hold to Buy. For the first quarter, Semtech had an EPS of $0.02, compared to year-ago quarter EPS of $0.80. The current stock performance of Semtech shows a 52-week-high of $35.68 and a 52-week-low of $17.82. Moreover, at the end of the last trading period, the closing price was at $25.36.

TD Cowen upgraded the previous rating for Constellation Brands Inc STZ from Market Perform to Outperform. Constellation Brands earned $2.91 in the first quarter, compared to $2.66 in the year-ago quarter. The stock has a 52-week-high of $273.65 and a 52-week-low of $208.12. At the end of the last trading period, Constellation Brands closed at $257.50.

According to Exane BNP Paribas, the prior rating for American Airlines Group Inc AAL was changed from Neutral to Outperform. American Airlines Group earned $1.92 in the second quarter, compared to $0.76 in the year-ago quarter. The current stock performance of American Airlines Group shows a 52-week-high of $19.08 and a 52-week-low of $11.65. Moreover, at the end of the last trading period, the closing price was at $14.30.

For Toast Inc TOST, UBS upgraded the previous rating of Neutral to Buy. In the second quarter, Toast showed an EPS of $0.19, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $27.00 and a 52-week-low of $15.77. Toast closed at $21.67 at the end of the last trading period.

According to Baird, the prior rating for AeroVironment Inc AVAV was changed from Neutral to Outperform. For the first quarter, AeroVironment had an EPS of $1.00, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $112.39 and a 52-week-low of $74.91. At the end of the last trading period, AeroVironment closed at $95.29.

According to B of A Securities, the prior rating for Adecoagro SA AGRO was changed from Underperform to Neutral. Adecoagro earned $0.40 in the second quarter, compared to $0.40 in the year-ago quarter. The stock has a 52-week-high of $11.75 and a 52-week-low of $6.96. At the end of the last trading period, Adecoagro closed at $11.55.

According to Keybanc, the prior rating for Celanese Corp CE was changed from Sector Weight to Overweight. For the second quarter, Celanese had an EPS of $2.17, compared to year-ago quarter EPS of $4.99. The current stock performance of Celanese shows a 52-week-high of $129.27 and a 52-week-low of $86.73. Moreover, at the end of the last trading period, the closing price was at $126.35.

See all analyst ratings upgrades.

Downgrades

For Plains GP Holdings LP PAGP, Citigroup downgraded the previous rating of Buy to Neutral. In the second quarter, Plains GP Holdings showed an EPS of $0.25, compared to $0.30 from the year-ago quarter. The current stock performance of Plains GP Holdings shows a 52-week-high of $16.28 and a 52-week-low of $10.45. Moreover, at the end of the last trading period, the closing price was at $16.05.

According to Longbow Research, the prior rating for Allegion PLC ALLE was changed from Buy to Neutral. In the second quarter, Allegion showed an EPS of $1.76, compared to $1.37 from the year-ago quarter. The current stock performance of Allegion shows a 52-week-high of $128.36 and a 52-week-low of $87.73. Moreover, at the end of the last trading period, the closing price was at $111.14.

According to Wells Fargo, the prior rating for Enbridge Inc ENB was changed from Overweight to Equal-Weight. For the second quarter, Enbridge had an EPS of $0.51, compared to year-ago quarter EPS of $0.53. The stock has a 52-week-high of $43.03 and a 52-week-low of $33.96. At the end of the last trading period, Enbridge closed at $35.29.

According to Exane BNP Paribas, the prior rating for Southwest Airlines Co LUV was changed from Outperform to Neutral. In the second quarter, Southwest Airlines showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. The current stock performance of Southwest Airlines shows a 52-week-high of $40.38 and a 52-week-low of $28.40. Moreover, at the end of the last trading period, the closing price was at $30.77.

According to UBS, the prior rating for Block Inc SQ was changed from Buy to Neutral. In the second quarter, Block showed an EPS of $0.39, compared to $0.18 from the year-ago quarter. At the moment, the stock has a 52-week-high of $89.97 and a 52-week-low of $51.34. Block closed at $58.74 at the end of the last trading period.

Morgan Stanley downgraded the previous rating for Stem Inc STEM from Overweight to Equal-Weight. In the second quarter, Stem showed an EPS of $0.26, compared to $0.21 from the year-ago quarter. The stock has a 52-week-high of $18.01 and a 52-week-low of $3.71. At the end of the last trading period, Stem closed at $5.01.

For Plains All American Pipeline LP PAA, Citigroup downgraded the previous rating of Buy to Neutral. Plains All American earned $0.25 in the second quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $15.49 and a 52-week-low of $10.17. At the end of the last trading period, Plains All American closed at $15.32.

According to Citigroup, the prior rating for Kinetik Holdings Inc KNTK was changed from Buy to Neutral. For the second quarter, Kinetik Holdings had an EPS of $0.41, compared to year-ago quarter EPS of $0.06. The stock has a 52-week-high of $40.59 and a 52-week-low of $26.32. At the end of the last trading period, Kinetik Holdings closed at $33.86.

According to Goldman Sachs, the prior rating for Olin Corp OLN was changed from Buy to Neutral. In the second quarter, Olin showed an EPS of $1.13, compared to $2.76 from the year-ago quarter. The current stock performance of Olin shows a 52-week-high of $64.70 and a 52-week-low of $41.34. Moreover, at the end of the last trading period, the closing price was at $51.11.

Brookline Capital downgraded the previous rating for Procaps Group SA PROC from Buy to Hold. For the second quarter, Procaps Gr had an EPS of $0.27, compared to year-ago quarter EPS of $0.07. The current stock performance of Procaps Gr shows a 52-week-high of $8.41 and a 52-week-low of $3.68. Moreover, at the end of the last trading period, the closing price was at $3.94.

See all analyst ratings downgrades.

Initiations

Capital One initiated coverage on Cheniere Energy Inc LNG with an Overweight rating. The price target for Cheniere Energy is set to $200.00. Cheniere Energy earned $5.61 in the second quarter, compared to $2.90 in the year-ago quarter. The current stock performance of Cheniere Energy shows a 52-week-high of $182.30 and a 52-week-low of $135.00. Moreover, at the end of the last trading period, the closing price was at $166.18.

Argus Research initiated coverage on Kenvue Inc KVUE with a Hold rating. For the second quarter, Kenvue had an EPS of $0.32, compared to year-ago quarter EPS of $0.43. The current stock performance of Kenvue shows a 52-week-high of $27.80 and a 52-week-low of $22.36. Moreover, at the end of the last trading period, the closing price was at $22.61.

With a Buy rating, Lake Street initiated coverage on PetIQ Inc PETQ. The price target seems to have been set at $28.00 for PetIQ. PetIQ earned $0.46 in the second quarter, compared to $0.51 in the year-ago quarter. The current stock performance of PetIQ shows a 52-week-high of $20.86 and a 52-week-low of $6.69. Moreover, at the end of the last trading period, the closing price was at $18.19.

Oppenheimer initiated coverage on Freightos Ltd CRGO with an Outperform rating. The price target for Freightos is set to $5.00. For the second quarter, Freightos had an EPS of $0.10, compared to year-ago quarter EPS of $0.77. The current stock performance of Freightos shows a 52-week-high of $31.15 and a 52-week-low of $1.85. Moreover, at the end of the last trading period, the closing price was at $2.70.

B. Riley Securities initiated coverage on Denali Therapeutics Inc DNLI with a Buy rating. The price target for Denali Therapeutics is set to $38.00. Denali Therapeutics earned $1.30 in the second quarter, compared to $0.48 in the year-ago quarter. The current stock performance of Denali Therapeutics shows a 52-week-high of $34.78 and a 52-week-low of $21.74. Moreover, at the end of the last trading period, the closing price was at $23.84.

For The Trade Desk Inc TTD, William Blair initiated coverage, by setting the current rating at Outperform. In the second quarter, Trade Desk showed an EPS of $0.28, compared to $0.20 from the year-ago quarter. The current stock performance of Trade Desk shows a 52-week-high of $91.85 and a 52-week-low of $39.44. Moreover, at the end of the last trading period, the closing price was at $81.42.

With a Equal-Weight rating, Morgan Stanley initiated coverage on Penumbra Inc PEN. The price target seems to have been set at $265.00 for Penumbra. Penumbra earned $0.43 in the second quarter, compared to $0.01 in the year-ago quarter. The current stock performance of Penumbra shows a 52-week-high of $348.67 and a 52-week-low of $145.50. Moreover, at the end of the last trading period, the closing price was at $262.10.

HC Wainwright & Co. initiated coverage on Bitdeer Technologies Group BTDR with a Buy rating. The price target for Bitdeer Technologies is set to $20.00. In the second quarter, Bitdeer Technologies showed an EPS of $0.36, compared to $0.14 from the year-ago quarter. The current stock performance of Bitdeer Technologies shows a 52-week-high of $14.60 and a 52-week-low of $4.60. Moreover, at the end of the last trading period, the closing price was at $12.75.

Barclays initiated coverage on Intapp Inc INTA with an Overweight rating. The price target for Intapp is set to $43.00. The stock has a 52-week-high of $50.46 and a 52-week-low of $13.70. At the end of the last trading period, Intapp closed at $37.98.

HSBC initiated coverage on Laboratory Corp of America Holdings LH with a Hold rating. The price target for Laboratory Corp is set to $210.00. For the second quarter, Laboratory Corp had an EPS of $3.42, compared to year-ago quarter EPS of $4.04. The current stock performance of Laboratory Corp shows a 52-week-high of $258.90 and a 52-week-low of $200.56. Moreover, at the end of the last trading period, the closing price was at $204.45.

HSBC initiated coverage on Zoetis Inc ZTS with a Buy rating. The price target for Zoetis is set to $230.00. In the second quarter, Zoetis showed an EPS of $1.41, compared to $1.20 from the year-ago quarter. The current stock performance of Zoetis shows a 52-week-high of $194.99 and a 52-week-low of $124.35. Moreover, at the end of the last trading period, the closing price was at $190.43.

With a Hold rating, HSBC initiated coverage on UnitedHealth Group Inc UNH. The price target seems to have been set at $540.00 for UnitedHealth Group. In the second quarter, UnitedHealth Group showed an EPS of $6.14, compared to $5.57 from the year-ago quarter. The current stock performance of UnitedHealth Group shows a 52-week-high of $557.99 and a 52-week-low of $445.68. Moreover, at the end of the last trading period, the closing price was at $480.81.

HSBC initiated coverage on LivaNova PLC LIVN with a Hold rating. The price target for LivaNova is set to $52.00. In the second quarter, LivaNova showed an EPS of $0.78, compared to $0.53 from the year-ago quarter. The stock has a 52-week-high of $59.86 and a 52-week-low of $40.26. At the end of the last trading period, LivaNova closed at $54.41.

HSBC initiated coverage on Johnson & Johnson JNJ with a Hold rating. The price target for Johnson & Johnson is set to $175.00. Johnson & Johnson earned $2.80 in the second quarter, compared to $2.59 in the year-ago quarter. The stock has a 52-week-high of $181.02 and a 52-week-low of $150.11. At the end of the last trading period, Johnson & Johnson closed at $160.68.

With a Buy rating, HSBC initiated coverage on IQVIA Holdings Inc IQV. The price target seems to have been set at $260.00 for IQVIA Hldgs. In the second quarter, IQVIA Hldgs showed an EPS of $2.43, compared to $2.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $241.86 and a 52-week-low of $165.75. IQVIA Hldgs closed at $220.89 at the end of the last trading period.

HSBC initiated coverage on Gilead Sciences Inc GILD with a Reduce rating. The price target for Gilead Sciences is set to $71.00. Gilead Sciences earned $1.34 in the second quarter, compared to $1.58 in the year-ago quarter. At the moment, the stock has a 52-week-high of $89.61 and a 52-week-low of $61.45. Gilead Sciences closed at $75.16 at the end of the last trading period.

HSBC initiated coverage on bluebird bio Inc BLUE with a Buy rating. The price target for bluebird bio is set to $4.21. In the second quarter, bluebird bio showed an EPS of $0.67, compared to $1.36 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.58 and a 52-week-low of $2.78. bluebird bio closed at $3.71 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Biogen Inc BIIB. The price target seems to have been set at $360.00 for Biogen. For the second quarter, Biogen had an EPS of $4.02, compared to year-ago quarter EPS of $5.25. At the moment, the stock has a 52-week-high of $334.58 and a 52-week-low of $194.48. Biogen closed at $266.29 at the end of the last trading period.

With a Buy rating, HSBC initiated coverage on Amgen Inc AMGN. The price target seems to have been set at $320.00 for Amgen. In the second quarter, Amgen showed an EPS of $5.00, compared to $4.65 from the year-ago quarter. The current stock performance of Amgen shows a 52-week-high of $296.63 and a 52-week-low of $211.71. Moreover, at the end of the last trading period, the closing price was at $254.01.

HSBC initiated coverage on Actinium Pharmaceuticals Inc ATNM with a Buy rating. The price target for Actinium Pharma is set to $11.60. For the second quarter, Actinium Pharma had an EPS of $0.58, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $15.11 and a 52-week-low of $5.87. Actinium Pharma closed at $6.53 at the end of the last trading period.

Raymond James initiated coverage on Fair Isaac Corp FICO with an Outperform rating. The price target for Fair Isaac is set to $1007.00. Fair Isaac earned $5.66 in the third quarter, compared to $4.47 in the year-ago quarter. The stock has a 52-week-high of $915.48 and a 52-week-low of $391.84. At the end of the last trading period, Fair Isaac closed at $892.71.

With a Buy rating, JonesTrading initiated coverage on Prime Medicine Inc PRME. The price target seems to have been set at $20.00 for Prime Medicine. For the second quarter, Prime Medicine had an EPS of $0.47, compared to year-ago quarter EPS of $1.76. The stock has a 52-week-high of $21.60 and a 52-week-low of $11.07. At the end of the last trading period, Prime Medicine closed at $12.00.

Baird initiated coverage on Lucid Group Inc LCID with a Neutral rating. The price target for Lucid Gr is set to $7.00. For the second quarter, Lucid Gr had an EPS of $0.40, compared to year-ago quarter EPS of $0.33. At the moment, the stock has a 52-week-high of $17.81 and a 52-week-low of $5.46. Lucid Gr closed at $6.30 at the end of the last trading period.

With an Outperform rating, Keefe, Bruyette & Woods initiated coverage on Federal Agricultural Mortgage Corp AGM. The price target seems to have been set at $220.00 for Federal Agricultural. For the second quarter, Federal Agricultural had an EPS of $3.86, compared to year-ago quarter EPS of $2.83. The current stock performance of Federal Agricultural shows a 52-week-high of $180.16 and a 52-week-low of $97.88. Moreover, at the end of the last trading period, the closing price was at $166.06.

Oppenheimer initiated coverage on Silk Road Medical Inc SILK with an Outperform rating. The price target for Silk Road Medical is set to $30.00. For the second quarter, Silk Road Medical had an EPS of $0.35, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $58.04 and a 52-week-low of $18.45. Silk Road Medical closed at $18.60 at the end of the last trading period.

Oppenheimer initiated coverage on LeMaitre Vascular Inc LMAT with an Outperform rating. The price target for LeMaitre Vascular is set to $70.00. LeMaitre Vascular earned $0.37 in the second quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $68.67 and a 52-week-low of $41.79. At the end of the last trading period, LeMaitre Vascular closed at $55.29.

See all analyst ratings initiations.